Neridronic acid for the treatment of bone metabolic diseases.
about
Pharmacological interventions for pain in children and adolescents with life-limiting conditionsGuidance for the diagnosis, prevention and therapy of osteoporosis in Italy.Clinical development of neridronate: potential for new applications.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Osteogenesis imperfecta and keratoconus in an Italian family.Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.
P2860
Neridronic acid for the treatment of bone metabolic diseases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neridronic acid for the treatment of bone metabolic diseases.
@ast
Neridronic acid for the treatment of bone metabolic diseases.
@en
type
label
Neridronic acid for the treatment of bone metabolic diseases.
@ast
Neridronic acid for the treatment of bone metabolic diseases.
@en
prefLabel
Neridronic acid for the treatment of bone metabolic diseases.
@ast
Neridronic acid for the treatment of bone metabolic diseases.
@en
P2093
P2860
P1476
Neridronic acid for the treatment of bone metabolic diseases
@en
P2093
Elena Fracassi
Ombretta Viapiana
Silvano Adami
P2860
P304
P356
10.1517/17425250903029190
P407
P577
2009-10-01T00:00:00Z